… With the availability of a vaccine to prevent human papillomavirus (HPV), the causative
agent for cervical cancer, the Honduran Secretary of Health undertook a cost-effectiveness …

… modelling the cost-effectiveness of screening for cervical cancer using human papillomavirus
(… Data were standardized to facilitate comparison of costs per life year or costs per QALY …

… In the present study, we perform a comprehensive cost-effectiveness analysis of primary
HPV testing versus primary cytology testing. We aim to find the most cost-effective combination …

… Objectives: The objective of this study was to simulate human papillomavirus (HPV) infection
in a heterosexual population and subsequently analyze the incremental costs and effects of …

… Human papillomavirus (HPV) plays a role in the development of benign and … Effectiveness
of a vaccination Strategy to prevent HPV-related diseases) evaluates 1) the cost-effectiveness …

… health outcomes and cost-effectiveness of quadrivalent human papillomavirus (HPV) 6/11/…
vaccination, we examined the incremental cost-effectiveness of vaccination strategies for 12 …

… vaccines against human papillomavirus (HPV), the necessary cause of cervical cancer,
have stirred debate in countries with secondary prevention programmes. The effectiveness of …

… The World Health Organization (WHO) recommends that the cost effectiveness of
introducing human papillomavirus (HPV) vaccination is considered before such a strategy is …

… the cost-effectiveness of a new, rapid human papillomavirus (… ), lifetime costs and incremental
cost-effectiveness ratios (cost per … This would be considered very cost-effective evaluated …

Objective To compare current cytological follow up of women treated for high‐grade cervical
intraepithelial neoplasia (CIN) with follow up by high‐risk human papillomavirus (HPV) …